Amendment to Schedule 13D for Artelo Biosciences, Inc.

This filing is an amendment to the Schedule 13D for Artelo Biosciences, Inc., submitted by Daniel S. Farb. The amendment updates the ownership details and transactions related to the company's common stock. As of the date of this filing, Farb directly owns 153,003 shares, constituting approximately 7.7% of the outstanding shares. Additionally, Farb holds 11,299 warrants with an exercise price of $10.00 per share, expiring in June 2030. These warrants are subject to a beneficial ownership limitation, currently set at 4.99%, which restricts Farb from exercising the warrants if it would result in ownership exceeding this limit. The filing also notes the delivery of 3 shares underlying previously held warrants, which are no longer held by Farb.